Major trial launches for aggressive lung cancer that has returned
NCT ID NCT07365241
Summary
This study compares an experimental drug called ABBV-706 against standard chemotherapy treatments for adults whose small cell lung cancer has returned or stopped responding to prior therapy. About 531 participants will be randomly assigned to receive either the new drug or one of three standard treatments to see which is more effective and safer. The main goals are to see if the new drug helps shrink tumors and helps people live longer compared to current options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.